Publication date: Jun 25, 2025
Persistent systematic inflammation and neuroinflammation are key features in patients with neurological symptoms of long COVID. It is characterized by the loss of dopamine-producing neurons in the substantia nigra, a region of the brain critical for motor control. Parkinsons Disease. Persistently circulating viral spike proteins are believed to trigger TLR-4 driven activation of NFB and the subsequent expression of inflammatory cytokines (IL-6, TNF, IFNg). The active agent is approved in the U. S. and in about 40 countries for related complications of advanced liver cirrhosis. Although BioVie Inc. believes such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Both neuroinflammation and insulin resistance are drivers of AD and PD.
| Concepts | Keywords |
|---|---|
| Americans | Al |
| Immunosuppressive | Alzheimers |
| Insulin | Bezisterim |
| Morning | Biovie |
| Clinical | |
| Disease | |
| Drug | |
| Insulin | |
| June | |
| Motor | |
| Parkinsons | |
| Pd | |
| Phase | |
| Symptoms | |
| Trial |
Semantics
| Type | Source | Name |
|---|---|---|
| drug | DRUGBANK | Nevirapine |
| disease | MESH | neurodegenerative disorders |
| disease | MESH | liver disease |
| drug | DRUGBANK | Nonoxynol-9 |
| drug | DRUGBANK | Dopamine |
| disease | MESH | tremors |
| disease | MESH | muscle rigidity |
| disease | MESH | cognitive impairment |
| disease | MESH | mood disorders |
| disease | MESH | facial expressions |
| drug | DRUGBANK | Isoxaflutole |
| drug | DRUGBANK | Levodopa |
| disease | MESH | complications |
| disease | MESH | dyskinesia |
| disease | MESH | inflammation |
| disease | MESH | insulin resistance |
| pathway | KEGG | Insulin resistance |
| disease | MESH | Neuroinflammation |
| disease | MESH | oxidative stress |
| pathway | REACTOME | Glucose metabolism |
| disease | MESH | disease progression |
| disease | MESH | drug interaction |
| disease | MESH | long COVID |
| drug | DRUGBANK | Carbidopa |
| disease | MESH | neurological disorders |
| disease | MESH | brain fog |
| drug | DRUGBANK | Terlipressin |
| disease | MESH | liver cirrhosis |
| disease | MESH | ascites |
| drug | DRUGBANK | Coenzyme M |
| pathway | REACTOME | Release |